Hebei Changshan Biochemical Pharmaceutical Co Ltd
SZSE:300255
Hebei Changshan Biochemical Pharmaceutical Co Ltd
SZSE:300255
Price:
47.8
CNY
1.16%
Market Cap:
¥43.9B
Relative Value
The Relative Value of one
Hebei Changshan Biochemical Pharmaceutical Co Ltd
stock under the Base Case scenario is
hidden
CNY.
Compared to the current market price of 47.8 CNY,
Hebei Changshan Biochemical Pharmaceutical Co Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Hebei Changshan Biochemical Pharmaceutical Co Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Hebei Changshan Biochemical Pharmaceutical Co Ltd Competitors
Hebei Changshan Biochemical Pharmaceutical Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Hebei Changshan Biochemical Pharmaceutical Co Ltd
SZSE:300255
|
43.9B CNY | 47.3 | -145.7 | -243.1 | -243.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
973.8B USD | 14.9 | 47.2 | 31.8 | 33.8 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
575.5B USD | 6.1 | 21.5 | 14.9 | 18.3 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
278.8B CHF | 4.5 | 29.7 | 12.6 | 14.6 | |
| CH |
|
Novartis AG
SIX:NOVN
|
231.7B CHF | 5.3 | 21.3 | 13.2 | 16.9 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
219.5B GBP | 5.2 | 32.4 | 15.4 | 22.6 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
292.2B USD | 4.5 | 16 | 10 | 11.7 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.5 | 13.6 | 9.9 | 11.6 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
157.5B USD | 2.5 | 20.3 | 7.5 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
123.8B USD | 2.6 | 17.5 | 6.9 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
